Summary
69 / 100 · Bulios Score
What speaks for it
- Out of every 100 EUR of revenue, 132 EUR is left as net profit.
- Revenue grew by 9.8% a year over the last 3 years.
- Analysts expect revenue to grow by 73% this fiscal year.
What to watch
- The share price is above the Bulios Fair Price.
- Earnings per share fell by 16% a year over the last 3 years.
- It passes only 2 of the 9 points of the Piotroski financial health test.
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Score in detailPrice
Is it expensive?
Looks expensiveBulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Today you pay 5.7 EUR for 1 EUR of yearly profit.
Valuation in detailIs it growing?
SlowlyRevenue (EUR)
Diluted EPS (EUR)
- Analyst estimate
Revenue grew by 16% a year over 5 years. Over the last 3 years it grew by 9.8% a year. For the next fiscal year analysts expect revenue to grow by 73%. Earnings per share fell by 16% a year over the last 3 years.
Growth in detailDoes it make money?
Very wellWhere 100 EUR of revenue goes
- Cost of sales 8.3 EUR
- Sales and administration 6.1 EUR
- Taxes and other -46 EUR
- Net profit 132 EUR
Net profit, industry median (REIT - Healthcare Facilities) 9.6 EUR
Out of every 100 EUR of revenue, 132 EUR is left as net profit.
Profitability in detailIs it financially healthy?
Debt is a burdenIts debt is larger than its cash. The debt score is high even so.
Financial health in detailDoes it pay a dividend?
Moderate, at risk- Yield
- 4.03%
- Paid out of profit
- 23%
- Raised in a row
- 1 year
You receive $3.32 per share a year. The payout is more than the company can comfortably cover.
Dividends in detailWhat do analysts expect?
Mildly positive- Buy 2
- Hold 0
- Sell 1
Today's price within the analysts' price targets
The average target of $75 is 9.0% below today's price. 67% of the analysts recommend buying.
Analysts in detailWhat does it earn on?
By product
The company reports no revenue by product.
By region
The company reports no revenue by region.